1. Vedeler CA, Matre R, Sadallah S, Schifferli J. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis. J Neuroimmunol. 1996;67(1):17–20.
2. Vedeler CA, Myhr KM, Nyland H. Fc receptors for immunoglobulin G: a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis. J Neuroimmunol. 2001;118(2):187–93.
3. Guan Y, Jakimovski D, Ramanathan M, Weinstock-Guttman B, Zivadinov R. The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging. Neural Regen Res. 2019;14(3):373–86.
4. Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler. 2010;16(7):855–61.
5. Etemadifar M, Roomizadeh P, Abtahi SH, Sajjadi S, Abedini A, Golabbakhsh A, et al. Linkage of multiple sclerosis and Guillain-Barre syndrome: a population-based survey in Isfahan, Iran. Autoimmune Dis. 2012;2012:232139.